Newron Pharmaceuticals Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Millions GBP. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Apr '25 Apr 22, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Market Capitalization	130	154	82	25	23	32	Upgrade
Market Cap Growth	86.40%	86.40%	231.73%	6.01%	-26.26%	-64.05%	Upgrade
Enterprise Value	165	185	110	39	28	19	Upgrade
Last Close Price	6.46	7.92	4.63	1.19	1.29	1.78	Upgrade
PE Ratio	9.93	11.72	-	-	-	-	Upgrade
PS Ratio	3.06	3.61	10.48	4.59	4.84	6.74	Upgrade
PB Ratio	107.94	127.32	-3.17	-1.99	8.98	2.06	Upgrade
P/TBV Ratio	107.94	127.32	-	-	8.98	2.06	Upgrade
EV/Sales Ratio	3.76	4.34	13.95	7.26	5.77	4.13	Upgrade
EV/EBITDA Ratio	7.34	8.52	-	-	-	-	Upgrade
EV/EBIT Ratio	7.39	8.53	-	-	-	-	Upgrade
Debt / Equity Ratio	34.62	34.62	-1.62	-3.25	13.87	1.53	Upgrade
Debt / EBITDA Ratio	1.91	1.91	-	-	-	-	Upgrade
Asset Turnover	1.15	1.15	0.29	0.14	0.11	0.09	Upgrade
Quick Ratio	2.42	2.42	0.62	5.50	10.58	5.50	Upgrade
Current Ratio	2.60	2.60	0.68	5.65	10.79	5.50	Upgrade
Return on Equity (ROE)	-	-	-	-	-146.43%	-77.71%	Upgrade
Return on Assets (ROA)	36.44%	36.44%	-23.05%	-18.96%	-15.19%	-20.26%	Upgrade
Return on Capital (ROIC)	46.45%	46.45%	-28.99%	-21.37%	-17.21%	-23.21%	Upgrade
Return on Capital Employed (ROCE)	64.80%	64.80%	-	-	-	-	Upgrade
Earnings Yield	10.07%	8.54%	-17.09%	-62.50%	-53.44%	-59.23%	Upgrade
FCF Yield	-11.20%	-9.50%	-10.70%	-39.69%	-41.12%	-44.07%	Upgrade
Buyback Yield / Dilution	-15.30%	-15.30%	-	-	-	-	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.